Almond, Stephen, Knapp, Martin 
ORCID: 0000-0003-1427-0215, Francois, Clement, Toumi, Mondher and Brugha, Traolach
(2004)
Relapse in schizophrenia: costs, clinical outcomes and quality of life.
British Journal of Psychiatry, 184 (4).
pp. 346-351.
ISSN 0007-1250
Abstract
Background: Relapse is one of the most costly aspects of schizophrenia. Aims: To compare costs, clinical outcomes and quality of life for patients who experienced relapse in schizophrenia with a control group who did not relapse. Method: Patients were randomly selected from current psychiatric case-loads drawn from urban and suburban areas of Leicester. Differences in costs and outcomes by relapse status in the previous 6 months were examined using parametric and non-parametric tests, and multivariate analysis was used to examine factors associated with relapse and costs. Results: Costs for the patients who relapsed were over four times higher than those for the non-relapse group. There were few statistically significant differences in clinical and quality of life measures by relapse status. Multivariate analyses suggested some significant correlates of relapse and costs. Conclusions: The higher costs associated with relapse will be of interest to policy-makers who face difficultchoices concerning new but more expensive treatments for patients with schizophrenia.
| Item Type: | Article |
|---|---|
| Official URL: | http://bjp.rcpsych.org |
| Additional Information: | © 2004 Royal College of Psychiatrists |
| Divisions: | Social Policy Care Policy and Evaluation Centre LSE Health |
| Subjects: | R Medicine > R Medicine (General) H Social Sciences > HV Social pathology. Social and public welfare. Criminology |
| Date Deposited: | 05 Sep 2008 14:21 |
| Last Modified: | 18 Nov 2024 08:00 |
| URI: | http://eprints.lse.ac.uk/id/eprint/15081 |
Actions (login required)
 |
View Item |
